Charles River Laboratories International (CRL) Acquisitions (2009 - 2024)

Charles River Laboratories International's Acquisitions history runs 14 years deep, the most recent figure standing at $5.5 million for Q2 2024.

• In Q2 2024, Acquisitions changed N/A year-over-year to $5.5 million; the TTM figure through Sep 2025 stood at $5.5 million (down 96.35% YoY), while the FY2024 annual figure was $5.5 million, down 97.19% from the prior year.
• Acquisitions for Q2 2024 stood at $5.5 million, down from $144.6 million in the prior quarter.
• The five-year high for Acquisitions was $906.3 million in Q2 2021, with the low at -$518000.0 in Q4 2020.
• The 5-year median for Acquisitions is $94.2 million (2021), against an average of $199.6 million.
• Peak annual rise in Acquisitions reached 38550.15% in 2020, while the deepest fall reached 1059.26% in 2020.
• Charles River Laboratories International's Acquisitions stood at -$518000.0 in 2020, then surged by 293.44% to $1.0 million in 2021, then jumped by 28182.63% to $283.4 million in 2022, then tumbled by 48.97% to $144.6 million in 2023, then plunged by 96.21% to $5.5 million in 2024.
• Business Quant data shows CRL's Acquisitions at $5.5 million in Q2 2024, $144.6 million in Q4 2023, and $50.2 million in Q2 2023.